January 30th, 2008

SpeculatingStocks.com Stock Pick: Thermogenesis Corporation (KOOL)

Stock Price: $1.69

ThermoGenesis Corporation engages in the design, manufacture, and marketing of automated and semi-automated devices, and single-use processing disposables in the United States. Its products enable hospitals and blood banks to manufacture a therapeutic dose of stem cells, wound healing proteins, or growth factors from a single unit of cord blood or the patient's own blood.

We believe KOOL is another stock that can benefit from a possible increase in stem cell funding and support. KOOL can benefit from a possible overall increase in the stem cell industry.

KOOL has around $31.30 million in cash and short-term investments with very little long-term debt and total liabilities of only $5.80 million. KOOL is trading at a market cap of only around $94.13 million.

The company provided an update on its upcoming second quarter report. KOOL expects to generate revenue in the range of $5.3 - $5.5 million, this would be a top-line increase of over 43% over the same period last year.

KOOL moved earlier this year from under $1.50 to over $2.00 and corrected down to its current price level. We believe investors will start to discover KOOL and find its current price level attractive.